Clinical Report: Hypersensitivity Reaction and Leukocytosis Induced by G-CSF

Overview

This report details a case of a 14-year-old female with a germ cell tumor who developed systemic hypersensitivity reactions and marked leukocytosis following the administration of granulocyte colony-stimulating factor (G-CSF). The findings underscore the need for clinical vigilance regarding G-CSF administration in pediatric patients.

Background

Chemotherapy-induced bone marrow suppression significantly increases the risk of febrile neutropenia in pediatric cancer patients. Granulocyte colony-stimulating factor (G-CSF) is widely used for prophylaxis and treatment of febrile neutropenia, but rare adverse events, including hypersensitivity reactions, can occur. Understanding these reactions is crucial for optimizing patient safety and treatment outcomes.

Data Highlights

No numerical data available.

Key Findings

Clinical Implications

Healthcare providers should maintain a high index of suspicion for hypersensitivity reactions in pediatric patients receiving G-CSF, especially after previous tolerability. Close monitoring and readiness to intervene are essential when administering G-CSF, particularly in those with a history of allergies or adverse reactions.

Conclusion

Reinforce the call for research on the safety of efbemalenograstim alfa-vuxw in pediatric patients.

Related Resources & Content

1. Frontiers in Pediatrics, 2026 -- Granulocyte Colony-Stimulating Factor-Induced Hypersensitivity Reaction with Leukocytosis in a Pediatric Germ Cell Tumor Patient: A Case Report
2. Frontiers in Pediatrics — Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge
3. Frontiers in Pediatrics — Hodgkin lymphoma with hypereosinophilia in a pediatric patient: case report and review of the literature
4. Frontiers in Oncology — Successful conversion therapy for presumed granulocyte colony-stimulating factor–producing hepatocellular carcinoma: a case report
5. Blood Cancer Journal — Impact of Granulocyte Colony-Stimulating Factor on Adverse Effects Following CAR T Cell Treatment for Lymphoma and Myeloma
6. Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update
7. WBC Growth Factors: ASCO Guideline Update | Journal of Clinical Oncology
8. Frontiers | Granulocyte Colony-Stimulating Factor-Induced Hypersensitivity Reaction with Leukocytosis in a Pediatric Germ Cell Tumor Patient: A Case Report